Role of protein arginine methyltransferase 5 in human cancers

Biomed Pharmacother. 2019 Jun:114:108790. doi: 10.1016/j.biopha.2019.108790. Epub 2019 Mar 20.

Abstract

Protein arginine methyltransferases (PRMTs) play important roles in protein methylation. PRMT5 is the major type II arginine methyltransferase that catalyzes the transfer of two methyl groups symmetrically to the arginine residues of either histone or non-histone proteins. In recent years, increasing evidence has shown that PRMT5, as an oncogene, plays an indispensable regulatory role in the pathological progression of several human cancers by promoting the proliferation, invasion, and migration of cancer cells. PRMT5 is overexpressed in many malignant tumors and plays an important role in the occurrence and development of cancer, which suggests that PRMT5 may become a potential biomarker or therapeutic target of cancer. This article reviews the biological function, mechanism, and clinical significance of PRMT5 in tumorigenesis.

Keywords: Biomarker; Cancer; Oncogene; PRMT5.

Publication types

  • Review

MeSH terms

  • Animals
  • Biomarkers, Tumor / metabolism
  • Histones / metabolism
  • Humans
  • Methylation
  • Neoplasms / metabolism*
  • Protein-Arginine N-Methyltransferases / metabolism*

Substances

  • Biomarkers, Tumor
  • Histones
  • Protein-Arginine N-Methyltransferases